WebJan 4, 2024 · Sema4 is an intelligent health company that uses genetic testing to create precision medicine from diagnosis to treatment stages of cancer, women’s health, carrier screens, and more. The tests are covered by most major insurance companies when ordered through a physician’s office and genetic counseling is available from the company. 3.5. WebDec 17, 2024 · While it is not clear why Sema4 has now chosen to exit the testing business, the state contracts for COVID testing were a lifeline for the company in the spring of 2024 when the pandemic struck ...
TrialJectory Achieves 500 Percent Year-Over-Year Growth as …
WebDid you know that only 40% of cancer patients go through NGS testing? That’s right! In spite of the importance of NGS testing, the majority of patients... WebMay 2, 2024 · Under the terms of the agreement, Sema4 has acquired GeneDx for an upfront payment of $150 million in cash, subject to adjustment, plus 80.0 million shares of Sema4’s Class A common stock, with up to an additional $150 million revenue-based milestones over the next two years (which will be payable in cash or shares of Sema4 Class A common … pup hypno
Healthcare Technology Week-In-Review - Solomon Partners
WebAug 27, 2024 · Deep cuts in Connecticut. The layoffs will affect 143 employees at Sema4’s headquarters at 333 Ludlow St. in Stamford’s South End; 15 employees at the laboratory at 62 Southfield Ave. in Stamford; and 81 employees at the lab at 1 Commercial St. in Branford, according to a letter the company sent last week to the state Department of Labor. WebFeb 10, 2024 · Sema4, an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company, and CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, today announced they have entered into a definitive business … WebNov 14, 2024 · Sema4, including GeneDx, performed 128,262 diagnostic tests in the quarter, excluding COVID-19 tests, 19 percent more than the 107,417 in Q3 2024 when calculated on a pro forma basis. The company ceased COVID-19 testing in Q1 of this year. pup engine oil